Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Heart Rate Impact on Central Hemodynamics in Sick Sinus Syndrome
NCT03245996Phase 4Completed
- Sponsor
- Tartu University Hospital
- Start
- Jun 2015
- Primary completion
- Sep 2016
- Modality
- Small Molecules
01
Overview
Phase 4 trial of atenolol, nebivolol and ivabradine in sick sinus syndrome (SSS), sponsored by Tartu University Hospital. Primary endpoints: Central systolic blood pressure and Systolic blood pressure amplification. Started Jun 2015; status: completed.
02
Drugs
atenololnebivololivabradine
03
Conditions
sick sinus syndrome (SSS)
Beyond the preview
Go deeper on NCT03245996.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03245996.